Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy

---

Yavas G., Celik E., Yavas C., Elsurer C., Afsar R.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, vol.22, no.4, pp.295-302, 2017 (ESCI, Scopus)

• Publication Type: Article / Article
• Volume: 22 Issue: 4
• Publication Date: 2017
• Doi Number: 10.1016/j.rpor.2017.01.004
• Journal Name: REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
• Page Numbers: pp.295-302
• Süleyman Demirel University Affiliated: No

Abstract

Aim: We aimed to evaluate impact of spironolactone (S) on cardiovascular toxicity of concomitant use of radiotherapy (RT) and trastuzumab (T).